The role of OX40-OX40L interactions in experimental colitis

The role of OX40-OX40L interactions in experimental colitis

Bibliographic Details
Main Author:	Bachler, Marcus A.
Published:	University of Southampton 2004
Subjects:	616.3447
Online Access:	http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.400511

Similar Items

Interaction between diet, genetic polymorphisms in glutathione peroxidases and susceptibility to ulcerative colitis
by: Qatatsheh, Alaaddin
Published: (2005)

Characterization of a murine model of colitis
by: Levison, Scott
Published: (2012)

The protective mechanisms of nicotine in relation to intestinal epithelial permeability and inflammation in ulcerative colitis
by: McGilligan, Victoria
Published: (2006)

The effects of dietary supplementation with n3 essential fatty acids in patients with ulcerative colitis
by: El-Tahir, Amin Mirghani
Published: (2003)

The contribution of fibroblast phenotype to stricture formation in Crohn's disease
by: Skelly, R. T.
Published: (2003)

OX40L–OX40 Signaling in Atopic Dermatitis
by: Masutaka Furue, et al.
Published: (2021-06-01)

The roles of CD40 and OX40 during the induction of T cell tolerance versus T cell immunity
by: Hochweller, Kristin
Published: (2004)

Research advances in the role of OX40/OX40L in the immune pathogenesis of chronic hepatitis
by: QIN Wei
Published: (2018-05-01)

Modulation of regulatory T cell suppression in tumors through OX40
by: Burocchi, Alessia
Published: (2012)

Reusing External Library Components in the Creek CBR System
by: Stiklestad, Erik
Published: (2007)

OX40 (CD134) and OX40 ligand, important immune checkpoints in cancer
by: Deng J, et al.
Published: (2019-09-01)

Increased Expressions of OX40 and OX40 Ligand in Patients with Primary Immune Thrombocytopenia
by: Dawei Cui, et al.
Published: (2019-01-01)

OX40/OX40L in systemic lupus erythematosus: Association with disease activity and lupus nephritis
by: Farres Mohamed, et al.
Published: (2011-01-01)

699 A differentiated anti-OX40 agonist BGB-A445 does not block OX40-OX40L interaction and reveals remarkable anti-tumor efficacy in preclinical models
by: Bo Zhang, et al.
Published: (2020-11-01)

The OX40/OX40L Axis Regulates T Follicular Helper Cell Differentiation: Implications for Autoimmune Diseases
by: NanNan Fu, et al.
Published: (2021-06-01)

OX40-OX40L interaction promotes proliferation and activation of lymphocytes via NFATc1 in ApoE-deficient mice.
by: Jinchuan Yan, et al.
Published: (2013-01-01)

Distinct roles for CD28 and OX40 signals in regulating naive and effector CD4 T cells
by: Wiggett, Helen Elizabeth
Published: (2003)

Mast Cell-Derived Exosomes Promote Th2 Cell Differentiation via OX40L-OX40 Ligation
by: Fei Li, et al.
Published: (2016-01-01)

Expression and significance of OX40/OX40L in peripheral blood of patients with autoimmune hepatitis, primary biliary cholangitis, and their overlap syndrome
by: WANG Weizhao
Published: (2020-12-01)

OX40L/OX40 Signal Promotes IL-9 Production by Mucosal MAIT Cells During Helicobacter pylori Infection
by: Siqi Ming, et al.
Published: (2021-03-01)

Enhancement of the Soluble Form of OX40 and OX40L Costimulatory Molecules but Reduction of the Membrane Form in Type 1 Diabetes (T1D)
by: Jingnan An, et al.
Published: (2019-01-01)

Ox-LDL increases OX40L in endothelial cells through a LOX-1-dependent mechanism
by: Q. Dong, et al.
Published: (2013-09-01)

Dual anti-OX40/IL-2 therapy augments tumor immunotherapy via IL-2R-mediated regulation of OX40 expression.
by: William L Redmond, et al.
Published: (2012-01-01)

OX40 facilitates control of a persistent virus infection.
by: Tobias Boettler, et al.
Published: (2012-09-01)

Breaking Immunological Tolerance through OX40 (CD134)
by: Pratima Bansal-Pakala, et al.
Published: (2001-01-01)

OX40 agonists and combination immunotherapy: putting the pedal to the metal
by: Stefanie N Linch, et al.
Published: (2015-02-01)

Tissue specific deletion of inhibitor of kappa B kinase 2 with OX40-Cre reveals the unanticipated expression from the OX40 locus in skin epidermis.
by: Georgina H Cornish, et al.
Published: (2012-01-01)

Pathogenic roles of CD14, galectin-3, and OX40 during experimental cerebral malaria in mice.
by: Miranda S Oakley, et al.
Published: (2009-08-01)

KSHV and immune system modulation : cloning, expression and functional studies of KSHV vOX2 (vOX2)
by: Rezaee, Seyyed A.
Published: (2006)

Therapeutic strategies for the costimulatory molecule OX40 in T-cell-mediated immunity
by: Yu Fu, et al.
Published: (2020-03-01)

Immuno-stimulation by OX40 ligand transgenic Ewing sarcoma cells
by: Dajana eReuter, et al.
Published: (2015-10-01)

Agonist redirected checkpoint, PD1-Fc-OX40L, for cancer immunotherapy
by: George Fromm, et al.
Published: (2018-12-01)

Correlation of peripheral blood COS, OX40 and CD40 expression with disease activity in patients with lupus nephritis
by: Wei Peng, et al.
Published: (2017-08-01)

Domain binding and isotype dictate the activity of anti-human OX40 antibodies
by: C Ian Mockridge, et al.
Published: (2020-07-01)

The OX40 Axis is Associated with Both Systemic and Local Involvement in Atopic Dermatitis
by: Julie Sophie Elsner, et al.
Published: (2020-03-01)

OX40 Regulates Both Innate and Adaptive Immunity and Promotes Nonalcoholic Steatohepatitis
by: Guangyong Sun, et al.
Published: (2018-12-01)

OX40 Gene and Serum Protein Expression Profiles in Patients with Parkinson’s Disease
by: Azadeh Seyedjoodaki, et al.
Published: (2018-04-01)

Expression of OX40 Gene and its Serum Levels in Neuromyelitis Optica Patients
by: Alidadiani Parya, et al.
Published: (2019-04-01)

ヒトOX40/gp34系の機能に関する研究
by: Kotani, Ai
Published: (2011)

Costimulation through OX40 is crucial for induction of an alloreactive human T cell response
by: Ukyo, Naoya
Published: (2011)